Literature DB >> 19076727

Variability and reproducibility of hepatic FDG uptake measured as SUV as well as tissue-to-blood background ratio using positron emission tomography in healthy humans.

Inge-Lis Kanstrup1, Thomas Levin Klausen, Jens Bojsen-Møller, Peter Magnusson, Bo Zerahn.   

Abstract

INTRODUCTION: To investigate variability and reproducibility of hepatic [(18)F]-2-fluoro-2-deoxy-D-glucose (FDG) uptake in healthy individuals.
METHODS: Static images were obtained 70 min after the injection of 160 MBq FDG in six healthy subjects at two occasions with 13 days' interval. FDG uptake was adjusted for tissue-to-blood background ratio (T/B), or measured as standardized uptake value (SUV). Small regions of interest (ROIs) of 10 cm(3) in two different hepatic regions were analysed as well as the total liver.
RESULTS: Mean SUV was 1.16 +/- 0.15 and mean T/B corrected values was 1.87 +/- 0.17. The maximal values were 2.70 (SUV) and 4.67 (T/B). Reproducibility was 6.7% for the mean SUV and 0.2% for the max SUV values. The corresponding figures for the T/B corrected mean values were 6.4% and for the max T/B values 13.0%. In general, the small ROIs had a comparable or even lower CV% for SUV values, but a higher CV% for T/B corrected values.
CONCLUSIONS: In normal subjects hepatic FDG-uptake is high and homogeneous with a low CV% between days. T/B corrected values are largely comparable to SUV values but not superior, probably due to the standardization of procedures and homogeneity of the subjects. The T/B corrected method is theoretically superior in a more inhomogeneous population or when using different scanners and is shown here to be easy to apply. Small ROIs of 10 cm(3) are representative with respect to mean FDG uptake in the total liver and reproducibility, but do not identify the max FDG uptake.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19076727     DOI: 10.1111/j.1475-097X.2008.00846.x

Source DB:  PubMed          Journal:  Clin Physiol Funct Imaging        ISSN: 1475-0961            Impact factor:   2.273


  7 in total

1.  Value of (18)F-FDG PET/CT for therapeutic assessment of patients with polymyalgia rheumatica receiving tocilizumab as first-line treatment.

Authors:  X Palard-Novello; S Querellou; M Gouillou; A Saraux; T Marhadour; F Garrigues; R Abgral; P Y Salaün; V Devauchelle-Pensec
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01-11       Impact factor: 9.236

2.  Hepatic FDG Uptake is not Associated with Hepatic Steatosis but with Visceral Fat Volume in Cancer Screening.

Authors:  Kyoungjune Pak; Seong-Jang Kim; In Joo Kim; Keunyoung Kim; Heeyoung Kim; So Jung Kim
Journal:  Nucl Med Mol Imaging       Date:  2012-06-21

3.  The distribution of FDG at PET examinations constitutes a relative mechanism: significant effects at activity quantification in patients with a high muscular uptake.

Authors:  Henry Lindholm; Ove Johansson; Cathrine Jonsson; Hans Jacobsson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-08-14       Impact factor: 9.236

4.  Prognostic relevance at 5 years of the early monitoring of neoadjuvant chemotherapy using (18)F-FDG PET in luminal HER2-negative breast cancer.

Authors:  Olivier Humbert; Alina Berriolo-Riedinger; Alexandre Cochet; Mélanie Gauthier; Céline Charon-Barra; Séverine Guiu; Isabelle Desmoulins; Michel Toubeau; Inna Dygai-Cochet; Charles Coutant; Pierre Fumoleau; François Brunotte
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-21       Impact factor: 9.236

5.  Predictive significance of standardized uptake value parameters of FDG-PET in patients with non-small cell lung carcinoma.

Authors:  X-Y Duan; W Wang; M Li; Y Li; Y-M Guo
Journal:  Braz J Med Biol Res       Date:  2015-02-03       Impact factor: 2.590

6.  Test-retest repeatability and interobserver variation of healthy tissue metabolism using 18F-FDG PET/CT of the thorax among lung cancer patients.

Authors:  Afnan A Malaih; Joel T Dunn; Lotte Nygård; David G Kovacs; Flemming L Andersen; Sally F Barrington; Barbara M Fischer
Journal:  Nucl Med Commun       Date:  2022-05-01       Impact factor: 1.698

7.  Multivariate analysis of various factors affecting background liver and mediastinal standardized uptake values.

Authors:  Manohar Kuruva; Bhagwant Rai Mittal; Mohammed Labeeb Abrar; Raghava Kashyap; Anish Bhattacharya
Journal:  Indian J Nucl Med       Date:  2012-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.